Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Vet Med Sci ; 75(12): 1551-6, 2013 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-23877843

RESUMO

The Long-Evans Cinnamon (LEC) rat, an animal model of human Wilson's disease, spontaneously develops fulminant hepatitis associated with severe jaundice at about 4 months of age. In this study, we examined the changes in gene expression during progression of acute hepatic injury. When levels of gene expression in the liver of LEC rats at 13 weeks of age were compared to those in rats at 4 weeks of age using oligonucleotide arrays, 1,620 genes out of 7,700 genes analyzed showed more than 2-fold differences. Expression levels of 11 of 29 genes related to stress-activating protein kinase (SAPK) changed by more than 2-fold in the liver of LEC rats, but none of the SAPK-related genes showed changes in expression levels in the liver of control rats. Activity of p38 mapk in the liver of LEC rats at 13 weeks of age was about 8.1-fold higher than that in rats at 4 weeks of age. When LEC rats were administered SB203580, a p38 mapk-specific inhibitor, by s.c. injection twice a week from 10 to 13 weeks of age, activities of p38 mapk in the liver, activities of AST and ALT and concentrations of bilirubin in sera of rats administered SB203580 significantly decreased compared to those in rats not administered. These results showed that the increase in activities of p38 mapk was related to the occurrence of acute hepatic injury in LEC rats.


Assuntos
Modelos Animais de Doenças , Regulação Enzimológica da Expressão Gênica/fisiologia , Degeneração Hepatolenticular/metabolismo , Fígado/metabolismo , Ratos Endogâmicos LEC , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo , Fatores Etários , Alanina Transaminase/sangue , Análise de Variância , Animais , Aspartato Aminotransferases/sangue , Eletroforese em Gel de Poliacrilamida , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Degeneração Hepatolenticular/enzimologia , Imidazóis/farmacologia , Piridinas/farmacologia , Ratos , Estatísticas não Paramétricas , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores
2.
J Vet Med Sci ; 71(11): 1541-4, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19959910

RESUMO

We have reported that treatment with trientine, Cu-chelating agent, inhibits tumor growth in a murine transplantation model using fibrosarcoma and induces apoptosis in tumor cells in vivo and in vitro. When fibrosarcoma cells were treated with 10 mM trientine, the activities of p38 MAPK in treated cells were approximately 3-4 times higher than those in untreated cells. Proportions of cells in which apoptosis was induced by trientine increased in an incubation time-dependent manner from days 2 to 6. The proportions of apoptotic cells in the cells treated with trientine and SB203580, an inhibitor of p38 MAPK, were approximately 50% in those of cells treated with trientine alone. The present results showed that the p38 MAPK pathway may play an important role in induction of apoptosis in fibrosarcoma cells by trientine.


Assuntos
Apoptose/efeitos dos fármacos , Quelantes/farmacologia , Fibrossarcoma/enzimologia , Trientina/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo , Animais , Linhagem Celular Tumoral , Cobre/metabolismo , Ativação Enzimática , Imidazóis/farmacologia , Camundongos , Piridinas/farmacologia , Transdução de Sinais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...